Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabigatran versus warfarin for intracardiac thrombus in nonvalvular atrial fibrillation or atrial flutter
ChiCTR-TRC-13003739Phase 4Completed
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dabigatran and warfarin in Atrial fibrillation (AFib) and atrial flutter (AFL) (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoints: Coagulation indicator, Echocardiography and 1 more. Started Jun 2013; status: completed.
02
Drugs
dabigatranwarfarin
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on ChiCTR-TRC-13003739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003739.